Hep G2（人肝癌細(xì)胞）(STR鑒定正確)

文獻(xiàn)(571) 說(shuō)明書

一鍵復(fù)制產(chǎn)品信息

英文名稱：Hep G2

貨號(hào)： CL-0103

規(guī)格：

1×10^6Cells/T25 1×10^6Cells/Vial×2Vials

套餐1

Hep G2（人肝癌細(xì)胞）

￥1600

Hep G2細(xì)胞專用培養(yǎng)基

￥ 350.00 ￥450

現(xiàn)單獨(dú)購(gòu)買該產(chǎn)品也可享受限時(shí)優(yōu)惠價(jià)

細(xì)胞培養(yǎng)最優(yōu)解！

套餐組合價(jià)

￥ 1950 ￥2050

產(chǎn)品信息

產(chǎn)品名稱	Hep G2（人肝癌細(xì)胞）
別稱	HEP-G2;Hep G2;HEP G2;HepG2;HEPG2
種屬	人
生長(zhǎng)特性	貼壁細(xì)胞
細(xì)胞形態(tài)	上皮細(xì)胞樣
凍存條件	凍存液：55% 基礎(chǔ)培養(yǎng)基+40% FBS+5% DMSO 溫度：液氮
培養(yǎng)方案A（默認(rèn)）	生長(zhǎng)培養(yǎng)基：MEM（含NEAA）+10% FBS+1% P/S 培養(yǎng)條件：氣相：空氣，95%；CO?，5%, 溫度：37℃
推薦傳代比例	1:2-1:3
推薦換液頻率	2-3次/周

參考資料(來(lái)源文獻(xiàn))

背景描述	Hep G2細(xì)胞是來(lái)自15歲男性白人的組織；Hep G2細(xì)胞形態(tài)為上皮細(xì)胞樣，模式染色體數(shù)為55；Hep G2細(xì)胞在免疫抑制小鼠中不致瘤。
年齡（性別）	15Y;Male
組織來(lái)源	肝細(xì)胞瘤
細(xì)胞類型	腫瘤細(xì)胞
腫瘤類型	肝細(xì)胞瘤
生物安全等級(jí)	BSL-1
保藏機(jī)構(gòu)	ATCC; HB-8065 BCRC; 60025 BCRJ; 0103 DSMZ; ACC-180 ECACC; 85011430

位點(diǎn)信息

鑒定圖

Changes in metabolites in raw and wine processed Corni Fructus combination metabolomics with network analysis focusing on potential hypoglycemic effects(2023)

期刊：Frontiers in Pharmacology

DOI：10.3389/fphar.2023.1173747

影響因子：5.6

引用產(chǎn)品： Hep G2 細(xì)胞
ETNPPL modulates hyperinsulinemia-induced insulin resistance through the SIK1/ROS-mediated inactivation of the PI3K/AKT signaling pathway in hepatocytes(2023)

期刊：JOURNAL OF CELLULAR PHYSIOLOGY

DOI：10.1002/jcp.30993

影響因子：5.600

引用產(chǎn)品：小鼠肝實(shí)質(zhì)細(xì)胞, Hep G2 細(xì)胞, 293T [HEK-293T] 細(xì)胞
Pomegranate-derived exosome-like nanovesicles ameliorate high-fat diet-induced nonalcoholic fatty liver disease via alleviating mitochondrial dysfunction(2023)

期刊：Journal of Functional Foods

DOI：10.1016/j.jff.2023.105734

影響因子：5.6

引用產(chǎn)品： Hep G2 細(xì)胞
Protective Effect of Water-Soluble Acacetin Prodrug on APAP-Induced Acute Liver Injury Is Associated with Upregulation of PPARγ and Alleviation of ER Stress(2023)

期刊：INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

DOI：10.3390/ijms241411320

影響因子：5.6

引用產(chǎn)品： Hep G2 細(xì)胞
Integrating network analysis and experimental validation to reveal the mechanism of pinocembrin in alleviating high glucose and free fatty acid-induced lipid accumulation in HepG2 cells(2023)

期刊：Journal of Functional Foods

DOI：10.1016/j.jff.2023.105879

影響因子：5.6

引用產(chǎn)品： Hep G2 細(xì)胞
Nuclear respiratory factor 1 drives hepatocellular carcinoma progression by activating LPCAT1-ERK1/2-CREB axis(2023)

期刊：Biology Direct

DOI：10.1186/s13062-023-00428-z

影響因子：5.5

引用產(chǎn)品： Hep G2 細(xì)胞, HuH-7 細(xì)胞, SNU182 細(xì)胞, DMEM高糖培養(yǎng)基
A novel class of C14-sulfonate-tetrandrine derivatives as potential chemotherapeutic agents for hepatocellular carcinoma(2023)

期刊：Frontiers in Chemistry

DOI：10.3389/fchem.2022.1107824

影響因子：5.500

引用產(chǎn)品： SMMC-7721 細(xì)胞, QGY-7701 細(xì)胞, SK-Hep-1 細(xì)胞, Hep G2 細(xì)胞
Prognostic, Immunological, and Mutational Analysis of MTA2 in Pan-Cancer and Drug Screening for Hepatocellular Carcinoma(2023)

期刊：Biomolecules

DOI：10.3390/biom13060883

影響因子：5.500

引用產(chǎn)品： Hep G2 細(xì)胞
ANGPTL3 negatively regulates IL-1β-induced NF-κB activation by inhibiting the IL1R1-associated signaling complex assembly(2023)

期刊：Journal of Molecular Cell Biology

DOI：10.1093/jmcb/mjad053

影響因子：5.5

引用產(chǎn)品： Hep G2 細(xì)胞
A Moexitecan Magnetic Liposomal Strategy for Ferroptosis-Enhanced Chemotherapy(2023)

期刊：Pharmaceutics

DOI：10.3390/pharmaceutics15072012

影響因子：5.4

引用產(chǎn)品： HT-29 細(xì)胞, Hep G2 細(xì)胞, PC-3 細(xì)胞, McCoy's 5A 培養(yǎng)基, MEM (含NEAA) 培養(yǎng)基, Ham's F-12K 培養(yǎng)基

Q1:在售的肝癌細(xì)胞，有具有干細(xì)胞特性的可以推薦嗎？

文獻(xiàn)顯示HepG2和HUH7細(xì)胞在特定條件下會(huì)表現(xiàn)出干細(xì)胞特性，可供參考： http://cellstemcell.org/index.php/PSC/article/view/407 https://cjb.ijournals.cn/html/cjbcn/2021/8/gc21082719.htm